MARKET

CERE

Cerevel Therapeutics Hldng Inc
CERE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-17.9795
-
14.49
8,191,474,701.12
CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR Newswire · 04/11 08:27
UPDATE 4-AbbVie banks on Alzheimer's therapy with $1.4 billion buy of Aliada
Reuters · 10/28/2024 12:15
UPDATE 3-AbbVie to buy Alzheimer's therapy developer Aliada for $1.4 bln
Reuters · 10/28/2024 12:15
UPDATE 2-Kailera Therapeutics nets $400 mln as weight-loss drug market heats up
Reuters · 10/01/2024 11:08
UPDATE 3-Kailera jumps on weight-loss drug bandwagon with $400 mln early-stage funding
Reuters · 10/01/2024 11:08
UPDATE 2-US FDA approves Bristol Myers' schizophrenia drug
Reuters · 09/26/2024 23:04
UPDATE 2-AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Reuters · 09/26/2024 12:26
*News On Cerevel Therapeutics Holdings Inc. (CERE) Now Under ABBV
Dow Jones · 08/01/2024 21:08
More

Webull offers Cerevel Therapeutics Hldng Inc stock information, including NASDAQ: CERE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERE stock methods without spending real money on the virtual paper trading platform.